# Keio Innovation Initiative

> Keio Innovation Initiative is a VC fund backing Health Care and Medical. See 90 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 90
- Last investment: Jul 2026
- Lead investor: 30%
- Fund size: $1.4B
- Last fund: Jan 2020
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/keio-innovation-initiative-inc/
- X (Twitter): https://twitter.com/keio_innovation
- Website: https://www.keio-innovation.co.jp/
- Facebook: https://www.facebook.com/keioinnovation/

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

## Contacts

5 contacts available for Keio Innovation Initiative. Shizune tracks 3 team members at Keio Innovation Initiative. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/keio-innovations-initiative?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $826k–$50M |
| Series A | $2.2M–$64M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 15 | 17% |
| Medical | 14 | 16% |
| Biotechnology | 14 | 16% |
| Manufacturing | 8 | 9% |
| Medical Device | 8 | 9% |

100 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 22 | 24% |
| Seed | 19 | 21% |
| Funding Round | 13 | 14% |
| Series B | 9 | 10% |
| Venture - Series Unknown | 7 | 8% |

11 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 60 | 67% |
| United Kingdom | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kotaro Yamagishi | Founder & CEO | 4 | https://shizune.co/investors/profile/kotaro-yamagishi |
| Shuichi Kinoshita | corporate officer | 2 | https://shizune.co/investors/profile/shuichi-kinoshita |
| Yusuke Satake | Principal | 4 | https://shizune.co/investors/profile/yusuke-satake |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Starlight Engine | Starlight Engine develops and commercializes fusion energy power plant technologies. | $37.4M | Seed | Jul 15, 2026 |  |
| Neusignal Therapeutics | Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. | $32.8M | Series B | Jun 30, 2026 |  |
| Neusignal Therapeutics | Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses. | $32.8M | Series B | Jun 30, 2026 |  |
| JiMED | JiMED designs & develops AI based brain-computer interface for implant in ALS patients to improve communication. | $2M |  | Jun 18, 2026 |  |
| Grafenary | Graphenary creates unique graphene optical devices using graphene materials with a variety of remarkable features. | $1.5M | Seed | Apr 27, 2026 |  |
| Orbital Lasers | Orbital is a space tech company that provides space debris business to remove debris and a satellite LiDAR business to provide surface data. | $19.2M | Series A | Mar 19, 2026 |  |
| Eco-Pork | Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite. | $9M | Venture - Series Unknown | Nov 28, 2025 |  |
| Surv Biopharma | Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products. | $14.1M | Series B | Nov 11, 2025 |  |
| Space quarters | Space Quarters is a manufacturing company that produces payload deploy and panels, and develops space assembly robotic systems. | $5M | Seed | Oct 15, 2025 |  |
| Z-Works | "Z-Works Life Engine" is a cloud-type IoT platform. Collect and analyze the data of the terminal equipped with Z-Wave on the cloud, you can browse various data with the smartphone and remotely control the terminal equipped with Z-Wave. | $4.7M |  | Oct 06, 2025 |  |

10 of 90 investments shown.

## Co-investors
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 23 deals together
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 22 deals together
- [JAFCO](https://shizune.co/investors/profile/jafco-co-ltd) — VC Fund, 16 deals together
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund, 14 deals together
- [Fast Track Initiative, Inc.](https://shizune.co/investors/profile/fast-track-initiative) — VC Fund, 12 deals together
- [DBJ Capital](https://shizune.co/investors/profile/dbj-capital) — VC Fund, 11 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [All VC Funds in Japan](https://shizune.co/investors/vc-funds-japan)
- [All Investors in Japan](https://shizune.co/investors/investors-japan)
- [Health Care Investors in Japan](https://shizune.co/investors/health-care-investors-japan)
- [Health Care VC Funds in Japan](https://shizune.co/investors/health-care-vc-funds-japan)
- [Health Care Investors in Asia](https://shizune.co/investors/health-care-investors-asia)
- [Health Care VC Funds in Asia](https://shizune.co/investors/health-care-vc-funds-asia)

## FAQ

### What does Keio Innovation Initiative invest in?

Keio Innovation Initiative invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Seed stage. Most of the 90 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Keio Innovation Initiative's check size?

Keio Innovation Initiative typically joins rounds of $826k–$50M at Seed and $2.2M–$64M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Keio Innovation Initiative participates in.

### How do I contact Keio Innovation Initiative?

Public channels for Keio Innovation Initiative include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Keio Innovation Initiative?

The team at Keio Innovation Initiative includes Kotaro Yamagishi (Founder & CEO), Shuichi Kinoshita (corporate officer) and Yusuke Satake (Principal). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co